Vaxcyte, Inc. (PCVX) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $317.21M | +54.4% |
| 2024 | $205.50M | +22.7% |
| 2023 | $167.45M | +218.6% |
| 2022 | $52.56M | +30.4% |
| 2021 | $40.32M | -14.2% |
| 2020 | $46.98M | +299.5% |
| 2019 | $11.76M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $317.21M | +54.4% |
| 2024 | $205.50M | +22.7% |
| 2023 | $167.45M | +218.6% |
| 2022 | $52.56M | +30.4% |
| 2021 | $40.32M | -14.2% |
| 2020 | $46.98M | +299.5% |
| 2019 | $11.76M | — |